In the News

The authors discuss the impact of community outreach on achieving diversity in clinical trials.

Our cell and gene therapy experts evaluate the probability of a future market for biosimilar versions of CAR-T therapies.

Krishna Cheriath comments on the future of artificial intelligence in clinical trials in this special edition of Contract Pharma.

Ding Ming comments on some of the key trends impacting clinical trials in the Asia-Pacific region.

The authors discuss the need to test for mycoplasmas and replication-competent viruses.

Our experts discuss the increased focus on patient diversity, functional service outsourcing and other trends impacting clinical trials.

Keri Henderson discusses why patients are more willing to participate in a clinical trial if it is offered remotely.

Our subject matter experts comment on growth areas in outsourcing and the challenges in today’s market.